ZLD 0.00% 73.5¢ zelira therapeutics limited

According to phase I clinical trials definition we couldn't have...

  1. 60 Posts.
    lightbulb Created with Sketch. 25
    • Zelira successfully completed a Phase 1 dose escalation study to assess the safety of itscannabis formulation (ZTL-103) in seven chronic pain patients already using high doses ofopioids.

    • ZTL-103 treatment was well tolerated with no serious adverse events

    Primary Endpoints Achieved:
    ZTL-103 is safe
    • No serious adverse events reported
    • Non-serious adverse events were mild and transient
    • Maximal dose was generally well tolerated

    Secondary Endpoints Achieved:
    •Pharmacokinetic Analysis:
    • ZTL-103 Treatment Improved Subjective Measures of Pain
    • ZTL-103 Treatment Improved Subjective Measures of Anxiety, Stress and Depression

    Not expecting much impact to the SP, however, next target is insomnia & HOPE products sales and that's where I believe the SP will go to mid-late teens easily.. 3-6 months I HOPE!
    We should see some smart money coming in between now and then..

    GLTAH & please DYOR!
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
73.5¢
Change
0.000(0.00%)
Mkt cap ! $8.340M
Open High Low Value Volume
72.0¢ 73.5¢ 72.0¢ $2.874K 3.985K

Buyers (Bids)

No. Vol. Price($)
1 1251 72.0¢
 

Sellers (Offers)

Price($) Vol. No.
73.5¢ 13897 2
View Market Depth
Last trade - 11.45am 04/09/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.